Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126414322 | 12641432 | 2 | F | 20160726 | 20160810 | 20160811 | EXP | US-ELI_LILLY_AND_COMPANY-US201608004315 | ELI LILLY AND CO | 0.00 | A | F | Y | 0.00000 | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126414322 | 12641432 | 1 | PS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | Y | 20509 | INJECTION | ||||||||
| 126414322 | 12641432 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | Unknown | UNK, UNKNOWN | Y | 0 | |||||||||
| 126414322 | 12641432 | 3 | C | CISPLATIN. | CISPLATIN | 1 | Unknown | UNK, UNKNOWN | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126414322 | 12641432 | 1 | Non-small cell lung cancer |
| 126414322 | 12641432 | 2 | Non-small cell lung cancer |
| 126414322 | 12641432 | 3 | Non-small cell lung cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126414322 | 12641432 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126414322 | 12641432 | Off label use | |
| 126414322 | 12641432 | Pulmonary fibrosis | |
| 126414322 | 12641432 | Stress cardiomyopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |